Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy

• Published in: Pathology international Vol. 56; no. 6; pp. 296 - 300
• Main Authors: Ichimura, Eiji, Yamada, Masatoshi, Nishikawa, Kiyohiro, Abe, Fuminori, Nakajima, Takashi
• Format: Journal Article
• Language: English
• Published: Melbourne, Australia Blackwell Publishing Asia 01.06.2006
• Subjects: Adjuvants, Immunologic - therapeutic use; Adult; Aged; Aged, 80 and over; aminopeptidase N; Bestatin; Biomarkers, Tumor - metabolism; Carcinoma, Squamous Cell - drug therapy; Carcinoma, Squamous Cell - enzymology; Carcinoma, Squamous Cell - pathology; CD13; CD13 Antigens - antagonists & inhibitors; CD13 Antigens - metabolism; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Leucine - analogs & derivatives; Leucine - therapeutic use; lung carcinoma; Lung Neoplasms - drug therapy; Lung Neoplasms - enzymology; Lung Neoplasms - pathology; Male; Middle Aged; squamous cell carcinoma; Tissue Array Analysis
• ISSN: 1320-5463; 1440-1827
• DOI: 10.1111/j.1440-1827.2006.01963.x

Bestatin, a specific inhibitor of aminopeptidase N (CD13), has been reported to prolong survival time in patients with completely resected stage I lung squamous cell carcinoma. Considering the antitumor mechanism of Bestatin, it is interesting to know whether CD13 is expressed in human lung squamous cell carcinoma. The immunohistochemical expression of CD13 was examined in human lung carcinoma and the question of whether CD13 was immunohistochemically expressed in the interstitial tissue was investigated, mainly in the fibroblasts and blood vessels, surrounding the tumor nests of various kinds of non‐small cell lung cancers, especially of squamous cell carcinomas. In Japanese squamous cell carcinoma of the lung, 38 (61.3%) out of 62 cancers were positively stained in the same manner on immunohistochemistry for CD13. The area of interstitial tissue positively stained for CD13 varied depending on the case. To confirm the cell nature of the interstitial tissue with CD13 positivity, double immunohistochemistry using CD34 and α‐smooth muscle actin was performed. Double immunohistochemistry showed that the majority of CD13‐positive cells were slender fibroblastic cells around the blood vessels and some endothelial cells.